Patanjali Moves Delhi High Court Against Order to Delete “Ordinary Chyawanprash” Ad Lines in Dabur Dispute

Patanjali has appealed a Delhi HC order that forced it to remove lines like “Why settle for ordinary Chyawanprash made with 40 herbs?” from its ads. Dabur alleged the campaign disparaged its product, while Patanjali claims it was mere puffery and fair advertising.

Misleading Medical Ads Case: Supreme Court Ends IMA Plea, Clears Path for AYUSH Ads Without Prior State Nod

The Supreme Court closed the IMA’s case against Patanjali over misleading ads and lifted its stay on the Centre’s deletion of Rule 170. AYUSH medicine ads can now run without prior State licensing approval.

Patanjali Ayurved & IMA | SC Grills Central Government on Directive to AYUSH Authorities Regarding Misleading Ads

The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.